Table 2

Patient characteristics

No. of patients
Institution
 Washington University35
 Syracuse Upstate Medical University/VAMC10
 Duke University8
 Durham VAMC5
Gender
 Males: 37
 Females: 21
Age (years)
 Mean: 65
 Range: 38–83
Stage
 IIIA: 14
 IIIB: 8
 IV: 36
Tumor histology
 Adenocarcinoma: 18
 Adenosquamous: 2
 Large cell neuroendocrine: 2
 Large cell: 19
 Squamous: 17
No. of patients
Chemotherapy given
 Carboplatin + paclitaxel29
 Carboplatin + gemcitabine8
 Carboplatin + vinorelbine5
 Cisplatin + etoposide1
 Gemcitabine + docetaxel2
 Gemcitabine + irinotecan1
 Vinorelbine + docetaxel2
 Gemcitabine4
 Vinorelbine4
 Paclitaxel2
Distribution of responses
 PR: 10
 Stable: 29
 Progression: 19
Status at last follow-up
 Alive with tumor: 23
 Dead of tumor: 35
Follow-up time (months)
 Median: 8.1
 Range: 1.3–20.6